Guardant Health, Inc.

GH Stock Healthcare Medical - Diagnostics & Research
$164.41
+5.39 (+3.39%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+3.5%
3 Months
+26.3%
YTD
+61.0%
1 Year
+143.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
58.7%
Largest decline max drawdown, since Aug 2025
-33.0%
Risk-adjusted return Sharpe ratio, 1-year
1.80

Own GH?

See how GH contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.